Nanobiotix Announces Closing of the Remaining $4.8 Million Investment From Johnson & Johnson Innovation – JJDC, Inc.
Benzinga
DECEMBER 4, 2023
million of the Company's restricted ADSs (the " Placement Amount "), exempt from the registration requirements of the Securities Act of 1933, as amended. Aggregate gross proceeds of approximately €50.9 million (equivalent to approximately $53.8 million) received by NANOBIOTIX has increased to approximately €55.5
45 
Let's personalize your content